Durability of the binding inhibition of albumin coating on tympanostomy tubes

International Journal of Pediatric Otorhinolaryngology

Volumn 67, Issue 2, 2003, Pages 157-164

  Kinnari, Teemu J ^a   Salonen, Eeva Marjatta ^a   Jero, Jussi ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Albumin coating; Durability; Otitis media with effusion; Tube occlusion; Tympanostomy tube

Indexed keywords

ADHESIVE AGENT; FIBRONECTIN; HUMAN SERUM ALBUMIN; SILICON; TITANIUM;

ARTICLE; BINDING KINETICS; EXUDATE; ISOTOPE LABELING; MATERIAL COATING; MATERIALS TESTING; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TYMPANOSTOMY TUBE;

ALBUMINS; BINDING SITES; BIOFILMS; COATED MATERIALS, BIOCOMPATIBLE; EQUIPMENT DESIGN; EQUIPMENT FAILURE; EQUIPMENT SAFETY; FIBRONECTINS; HUMANS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MIDDLE EAR VENTILATION; POSTOPERATIVE COMPLICATIONS; PROBABILITY; SENSITIVITY AND SPECIFICITY; SURFACE PROPERTIES;

EID: 12244303636     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5876(02)00364-6     Document Type: Article

References (13)

1. Gebhart D.E. Tympanostomy tubes in the otitis media-prone child. Laryngoscope. 91:1981;849-866.
2. Weigel M.T., Parker M.Y., Goldsmith M.M., Postma D.S., Pillsbury H.C. A prospective randomized study of four commonly used tympanostomy tubes. Laryngoscope. 99:1989;252-256.
3. Handler S.D., Miller L., Potsic W.P., Wetmore R.F., Marsh R.R. A controlled study of a 'new' ventilating tube; the gold standard? Int. J. Pediatr. Otorhinolaryngol. 12:1986;33-38.
4. Handler S.D., Miller L., Potsic W.P., Wetmore R.F., Marsh R.R. A prospective study of titanium ventilation tubes. Int. J. Pediatr. Otorhinolaryngol. 16:1988;55-60.
5. Karlan M.S., Skobel B., Grizzard M., Cassisi N.J., Singleton G.T., Buscemi P., et al. Myringotomy tube materials: bacterial adhesion and infection. Otolaryngol. Head Neck Surg. 88:1980;783-794.
6. Kinnari T.J., Salonen E.-M., Jero J. New method for coating tympanostomy tubes to prevent tube occlusions. Int. J. Pediatr. Otorhinolaryngol. 58:2001;107-111.
7. al-Khaffaf H., Charlesworth D. Albumin-coated vascular prostheses: a five-year follow-up. J. Vasc. Surg. 23:1996;686-690.
8. An Y.H., Stuart G.W., McDowell S.J., McDaniel S.E., Kang Q., Friedman R.J. Prevention of bacterial adherence to implant surfaces with a cross-linked albumin coating in vitro. J. Orthop. Res. 14:1996;846-849.
9. An Y.H., Bradley J., Powers D.L., Friedman R.J. The prevention of prosthetic infection using a cross-linked albumin coating in a rabbit model. J. Bone Joint Surg. Br. 79:1997;816-819.
10. Chang T.M. Platelet-surface interaction: effect of albumin coating or heparin complexing on thrombogenic surfaces. Can. J. Physiol. Pharmacol. 52:1974;275-285.
11. Marois Y., Chakfé N., Guidoin R., Duhamel R.C., Roy R., Marois M., et al. An albumin-coated polyester arterial graft: in vivo assessment of biocompatibility and healing characteristics. Biomaterials. 17:1996;3-14.
12. Remuzzi A., Boccardo P. Albumin treatment reduces in vitro platelet deposition to PMMA dialysis membrane. Int. J. Artif. Organs. 16:1993;128-131.
13. Erstad B.L. Viral infectivity of albumin and plasma protein fraction. Pharmacotherapy. 16:1996;996-1000.